Table 5

RRs with 95% CIs for associations of time-dependent average annual residential UVR in a 20-km radius, categorized into California statewide quartiles, with risk of CLL/SLL, MM, and HL

Average annual residential UVR in a 20-km radius (W-h/m2)Chronic lymphocytic leukemia/small lymphocytic lymphoma
Multiple myeloma
Pheterogeneity by lymphoma subtype‡Hodgkin lymphoma
Cases (n)*RR (95% CI)†Cases (n)*RR (95% CI)†Cases (n)*RR (95% CI)†
Minimum UVR        
    < 4915 58 1.00 (reference) 57 1.00 (reference)  27 1.00 (reference) 
    4915 to < 5026 48 1.03 (0.71-1.50) 36 0.76 (0.51-1.16)    
    5026 to 5100 7 0.54 (0.25-1.18) 11 0.82 (0.43-1.57)  10 1.26 (0.61-2.61) 
    ≥ 5100 7 0.46 (0.21-1.01) 10 0.71 (0.37-1.35) .29   
    Ptrend  .08  .15    
Median UVR        
    < 4915 39 1.00 (reference) 43 1.00 (reference)  14 1.00 (reference) 
    4915 to < 5026 35 1.15 (0.73-1.80) 29 0.81 (0.51-1.29)    
    5026 to < 5100 28 0.88 (0.55-1.43) 17 0.45 (0.26-0.79)  23 1.67 (0.86-3.26) 
    ≥ 5100 18 0.64 (0.37-1.12) 25 0.79 (0.48-1.28) .11   
    Ptrend  .17  .08    
Maximum UVR        
    < 4915 35 1.00 (reference) 39 1.00 (reference)  10 1.00 (reference) 
    4915 to 5026 19 1.11 (0.64-1.92) 20 1.07 (0.63-1.80)    
    5026 to < 5100 26 1.00 (0.60-1.65) 22 0.72 (0.43-1.21)  27 1.63 (0.79-3.37) 
    ≥ 5100 40 0.79 (0.50-1.24) 33 0.57 (0.36-0.90) .73   
    Ptrend  .30  .01§    
Average annual residential UVR in a 20-km radius (W-h/m2)Chronic lymphocytic leukemia/small lymphocytic lymphoma
Multiple myeloma
Pheterogeneity by lymphoma subtype‡Hodgkin lymphoma
Cases (n)*RR (95% CI)†Cases (n)*RR (95% CI)†Cases (n)*RR (95% CI)†
Minimum UVR        
    < 4915 58 1.00 (reference) 57 1.00 (reference)  27 1.00 (reference) 
    4915 to < 5026 48 1.03 (0.71-1.50) 36 0.76 (0.51-1.16)    
    5026 to 5100 7 0.54 (0.25-1.18) 11 0.82 (0.43-1.57)  10 1.26 (0.61-2.61) 
    ≥ 5100 7 0.46 (0.21-1.01) 10 0.71 (0.37-1.35) .29   
    Ptrend  .08  .15    
Median UVR        
    < 4915 39 1.00 (reference) 43 1.00 (reference)  14 1.00 (reference) 
    4915 to < 5026 35 1.15 (0.73-1.80) 29 0.81 (0.51-1.29)    
    5026 to < 5100 28 0.88 (0.55-1.43) 17 0.45 (0.26-0.79)  23 1.67 (0.86-3.26) 
    ≥ 5100 18 0.64 (0.37-1.12) 25 0.79 (0.48-1.28) .11   
    Ptrend  .17  .08    
Maximum UVR        
    < 4915 35 1.00 (reference) 39 1.00 (reference)  10 1.00 (reference) 
    4915 to 5026 19 1.11 (0.64-1.92) 20 1.07 (0.63-1.80)    
    5026 to < 5100 26 1.00 (0.60-1.65) 22 0.72 (0.43-1.21)  27 1.63 (0.79-3.37) 
    ≥ 5100 40 0.79 (0.50-1.24) 33 0.57 (0.36-0.90) .73   
    Ptrend  .30  .01§    
*

Case counts are classified according to the exposure category at the time of diagnosis.

†

All models were adjusted for age (as timescale) and calendar-year effects.

‡

Lymphoma subtypes include diffuse large B-cell lymphoma, follicular lymphoma CLL/SLL, and MM.

§

Pnonlinearity > .05.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal